Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Payables (2020 - 2025)

Historic Payables for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $62.5 million.

  • Cellebrite DI's Payables rose 1468.69% to $62.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.5 million, marking a year-over-year increase of 1468.69%. This contributed to the annual value of $63.3 million for FY2024, which is 4121.98% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Payables is $62.5 million, which was up 1468.69% from $68.0 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Payables ranged from a high of $68.0 million in Q2 2025 and a low of $35.6 million during Q2 2023
  • Over the past 5 years, Cellebrite DI's median Payables value was $47.5 million (recorded in 2022), while the average stood at $49.1 million.
  • Its Payables has fluctuated over the past 5 years, first crashed by 2494.05% in 2023, then skyrocketed by 6083.91% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Payables stood at $54.0 million in 2021, then decreased by 15.9% to $45.5 million in 2022, then dropped by 1.34% to $44.8 million in 2023, then skyrocketed by 41.22% to $63.3 million in 2024, then decreased by 1.33% to $62.5 million in 2025.
  • Its Payables was $62.5 million in Q3 2025, compared to $68.0 million in Q2 2025 and $53.9 million in Q1 2025.